Shattering barriers toward clinically meaningful MSC therapies

More than 1050 clinical trials are registered at FDA.gov that explore multipotent mesenchymal stromal cells (MSCs) for nearly every clinical application imaginable, including neurodegenerative and cardiac disorders, perianal fistulas, graft-versus-host disease, COVID-19, and cancer. Several companie...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Oren, Kuai, Rui, Siren, Erika M. J., Bhere, Deepak, Milton, Yuka, Nissar, Nabeel, De Biasio, Michael, Heinelt, Martina, Reeve, Brock, Abdi, Reza, Alturki, Meshael, Fallatah, Mohanad, Almalik, Abdulaziz, Alhasan, Ali H., Shah, Khalid, Karp, Jeffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439491/
https://www.ncbi.nlm.nih.gov/pubmed/32832666
http://dx.doi.org/10.1126/sciadv.aba6884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439491/
https://www.ncbi.nlm.nih.gov/pubmed/32832666
http://dx.doi.org/10.1126/sciadv.aba6884

Ejemplares similares